Funder: National Institutes of Health
Due Dates: March 7, 2026 (Full application)
Funding Amounts: Up to $500,000 per award; approx. $3,000,000 total program funding; ~6 awards expected; project period and budget per R01 guidelines.
Summary: Supports research to engineer improved stem cell-derived islet cell products for enhanced cell replacement therapies, focusing on preclinical testing and novel engineering strategies.
Key Information: Foreign (non-U.S.) organizations and foreign subawards/subcontracts are not eligible.